
Cartesian Therapeutics, Inc.
RNACHealthcare|Biotechnology|US
$7.53
+0.75 (+11.06%)
DCF Value
$3.97
Cash / Share
$4.06
Ownership Breakdown
38.3%
Float
30.3M
Shares Outstanding
11.6M
Float Shares
Major Holders (13)
Combined: 92.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Timothy A. Springer | IN, OO | 36.90% | 9,555,394 | Jan 15, 2025 | 13D/G |
| Squarepoint Capital LLP | Investment adviser | 8.30% | 2,209,601 | Mar 13, 2026 | 13D/G |
| Squarepoint Operations Private Limited | Investment adviser | 8.30% | 2,209,601 | Mar 13, 2026 | 13D/G |
| Squarepoint Ops LLC | Investment adviser | 8.30% | 2,209,601 | Mar 13, 2026 | 13D/G |
| Squarepoint (DIFC) Ltd | Investment adviser | 8.30% | 2,209,601 | Mar 13, 2026 | 13D/G |
| Squarepoint Master Fund Limited | Other | 8.20% | 2,178,652 | Mar 13, 2026 | 13D/G |
| Jpmorgan Chase & Co. | Holding company | 4.80% | 1,486,252 | Jul 22, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 3.00% | 799,743 | May 6, 2026 | 13D/G |
| FMR LLC | Holding company | 3.00% | 799,743 | May 6, 2026 | 13D/G |
| TAS Partners LLC | Other | 2.20% | 563,206 | Jan 15, 2025 | 13D/G |
| Chafen Lu | IN, OO | 1.40% | 350,740 | Jan 15, 2025 | 13D/G |
| Squarepoint Core Master Fund Limited | Other | 0.10% | 30,949 | Mar 13, 2026 | 13D/G |
| Barclays PLC | Holding company | 0.02% | 7,233 | Nov 6, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,066,205 acquired · 139,847 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Hoge Elizabeth | 10 percent owner | Apr 2, 2026 | OPTION EX. | 758,001 | — | — | Form 4 |
| Hoge Elizabeth | 10 percent owner | Apr 2, 2026 | OPTION EX. | 22,740.03 | — | — | Form 4 |
| Kalayoglu Murat | 10 percent owner | Apr 2, 2026 | OPTION EX. | 758,001 | — | — | Form 4 |
| Kalayoglu Murat | 10 percent owner | Apr 2, 2026 | OPTION EX. | 22,740.03 | — | — | Form 4 |
| Singer Michael | director | Mar 13, 2026 | GIFT | 6,555 | — | — | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 6, 2026 | SELL | 23,766 | $6.82 | $162.1K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 6, 2026 | SELL | 3,573 | $6.82 | $24.4K | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 6, 2026 | SELL | 10,591 | $6.82 | $72.2K | Form 4 |
| DeSilva Nishan M | director | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| DeSilva Nishan M | director | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 2, 2026 | AWARD | 415,700 | $6.76 | $2.8M | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 2, 2026 | AWARD | 143,200 | — | — | Form 4 |
| Malik Kemal | director | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| Malik Kemal | director | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 2, 2026 | AWARD | 77,000 | $6.76 | $520.5K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 2, 2026 | AWARD | 27,000 | — | — | Form 4 |
| ZENNER PATRICK J | director | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| ZENNER PATRICK J | director | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| Seymour June Ann | Chief Accounting Officer | Jan 2, 2026 | AWARD | 19,000 | $6.76 | $128.4K | Form 4 |
| Seymour June Ann | Chief Accounting Officer | Jan 2, 2026 | AWARD | 6,500 | — | — | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 2, 2026 | AWARD | 37,000 | — | — | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 2, 2026 | AWARD | 109,000 | $6.76 | $736.8K | Form 4 |
| BARABE TIMOTHY C | director | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| BARABE TIMOTHY C | director | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| English Emily | Chief Operations Officer | Jan 2, 2026 | AWARD | 24,000 | — | — | Form 4 |
| English Emily | Chief Operations Officer | Jan 2, 2026 | AWARD | 71,000 | $6.76 | $480.0K | Form 4 |
| Singer Michael | director | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| Singer Michael | director | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| Kalayoglu Murat | director, 10 percent owner: | Jan 2, 2026 | AWARD | 2,600 | — | — | Form 4 |
| Kalayoglu Murat | director, 10 percent owner: | Jan 2, 2026 | AWARD | 7,800 | $6.76 | $52.7K | Form 4 |
| English Emily | Chief Operations Officer | Dec 30, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| English Emily | Chief Operations Officer | Dec 30, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| Bot Adrian Ion | director | Dec 16, 2025 | AWARD | 17,200 | $8.29 | $142.6K | Form 4 |
| Bot Adrian Ion | director | Dec 16, 2025 | AWARD | 5,800 | — | — | Form 4 |
| Bot Adrian Ion | director: | Dec 16, 2025 | OTHER | 0 | — | — | Form 4 |
| BARABE TIMOTHY C | director | Dec 4, 2025 | BUY | 30,000 | $6.86 | $205.8K | Form 4 |
| English Emily | Chief Operations Officer | Nov 28, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| English Emily | Chief Operations Officer | Nov 28, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| Singer Michael | director | Nov 18, 2025 | GIFT | 20,000 | — | — | Form 4 |
| Seymour June Ann | Chief Accounting Officer | Oct 27, 2025 | AWARD | 50,000 | $8.85 | $442.5K | Form 4 |
| Seymour June Ann | officer | Oct 27, 2025 | OTHER | 0 | — | — | Form 4 |
| English Emily | Chief Operations Officer | May 12, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| English Emily | Chief Operations Officer | May 12, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| English Emily | Chief Operations Officer | Apr 15, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| English Emily | Chief Operations Officer | Apr 15, 2025 | OPTION EX. | 7,500 | $3.30 | $24.8K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 11, 2025 | BUY | 6,412 | $10.77 | $69.1K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 10, 2025 | BUY | 609 | $10.92 | $6.7K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 10, 2025 | BUY | 7,966 | $10.43 | $83.1K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 9, 2025 | BUY | 31 | $9.95 | $308.48 | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 9, 2025 | BUY | 7,342 | $9.43 | $69.2K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 11, 2025 | BUY | 36,338 | $10.77 | $391.5K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 10, 2025 | BUY | 3,451 | $10.92 | $37.7K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 10, 2025 | BUY | 45,144 | $10.43 | $471.1K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 9, 2025 | BUY | 178 | $9.95 | $1.8K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Apr 9, 2025 | BUY | 41,604 | $9.43 | $392.2K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Mar 20, 2025 | BUY | 54,889 | $15.59 | $855.6K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Mar 19, 2025 | BUY | 20,234 | $14.97 | $303.0K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Mar 18, 2025 | BUY | 14,740 | $14.42 | $212.6K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 14, 2025 | BUY | 4,022 | $18.00 | $72.4K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 13, 2025 | BUY | 8,983 | $17.78 | $159.7K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 13, 2025 | BUY | 7,962 | $16.86 | $134.2K | Form 4 |
| Jewell Christopher M | Chief Scientific Officer | Jan 10, 2025 | OPTION EX. | 9,000 | $3.23 | $29.1K | Form 4 |
| Jewell Christopher M | Chief Scientific Officer | Jan 10, 2025 | OPTION EX. | 9,000 | $3.23 | $29.1K | Form 4 |
| Kurtoglu Metin | Chief Technology Officer | Jan 3, 2025 | SELL | 2,417 | $16.72 | $40.4K | Form 4 |
| Kurtoglu Metin | Chief Technology Officer | Jan 6, 2025 | SELL | 2,458 | $16.83 | $41.4K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 3, 2025 | SELL | 932 | $16.72 | $15.6K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 6, 2025 | SELL | 948 | $16.83 | $16.0K | Form 4 |
| Jewell Christopher M | Chief Scientific Officer | Jan 3, 2025 | SELL | 1,264 | $16.72 | $21.1K | Form 4 |
| Jewell Christopher M | Chief Scientific Officer | Jan 6, 2025 | SELL | 1,286 | $16.83 | $21.6K | Form 4 |
| English Emily | Chief Operations Officer | Jan 3, 2025 | SELL | 891 | $16.72 | $14.9K | Form 4 |
| English Emily | Chief Operations Officer | Jan 6, 2025 | SELL | 906 | $16.83 | $15.2K | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 3, 2025 | SELL | 8,563 | $16.72 | $143.2K | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 6, 2025 | SELL | 8,708 | $16.83 | $146.6K | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 3, 2025 | SELL | 3,961 | $16.72 | $66.2K | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 6, 2025 | SELL | 4,028 | $16.83 | $67.8K | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 2, 2025 | AWARD | 57,500 | — | — | Form 4 |
| Brunn Carsten | director, officer: President and CEO | Jan 2, 2025 | AWARD | 169,100 | $16.93 | $2.9M | Form 4 |
| Jewell Christopher M | Chief Scientific Officer | Jan 2, 2025 | AWARD | 16,100 | — | — | Form 4 |
| Jewell Christopher M | Chief Scientific Officer | Jan 2, 2025 | AWARD | 47,400 | $16.93 | $802.5K | Form 4 |
| English Emily | Chief Operations Officer | Jan 2, 2025 | AWARD | 47,400 | $16.93 | $802.5K | Form 4 |
| English Emily | Chief Operations Officer | Jan 2, 2025 | AWARD | 16,100 | — | — | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 2, 2025 | AWARD | 22,000 | — | — | Form 4 |
| Davis Blaine | Chief Financial Officer | Jan 2, 2025 | AWARD | 64,600 | $16.93 | $1.1M | Form 4 |
| ZENNER PATRICK J | director | Jan 2, 2025 | AWARD | 2,600 | — | — | Form 4 |
| ZENNER PATRICK J | director | Jan 2, 2025 | AWARD | 7,800 | $16.93 | $132.1K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 2, 2025 | AWARD | 56,000 | $16.93 | $948.1K | Form 4 |
| Miljkovic Milos | Chief Medical Officer | Jan 2, 2025 | AWARD | 19,000 | — | — | Form 4 |
| Kalayoglu Murat | director, 10 percent owner: | Jan 2, 2025 | AWARD | 2,600 | — | — | Form 4 |
| Kalayoglu Murat | director, 10 percent owner: | Jan 2, 2025 | AWARD | 7,800 | $16.93 | $132.1K | Form 4 |
| BARABE TIMOTHY C | director | Jan 2, 2025 | AWARD | 2,600 | — | — | Form 4 |
| BARABE TIMOTHY C | director | Jan 2, 2025 | AWARD | 7,800 | $16.93 | $132.1K | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 2, 2025 | AWARD | 2,600 | — | — | Form 4 |
| SPRINGER TIMOTHY A | director, 10 percent owner: | Jan 2, 2025 | AWARD | 7,800 | $16.93 | $132.1K | Form 4 |
| Malik Kemal | director | Jan 2, 2025 | AWARD | 2,600 | — | — | Form 4 |
| Malik Kemal | director | Jan 2, 2025 | AWARD | 7,800 | $16.93 | $132.1K | Form 4 |
| Kurtoglu Metin | Chief Technology Officer | Jan 2, 2025 | AWARD | 16,100 | — | — | Form 4 |
| Kurtoglu Metin | Chief Technology Officer | Jan 2, 2025 | AWARD | 47,400 | $16.93 | $802.5K | Form 4 |
| Singer Michael | director | Jan 2, 2025 | AWARD | 2,600 | — | — | Form 4 |